HealthDay - WEDNESDAY, Feb. 22 (HealthDay News)—The U.S. Food and Drug
Administration plans to take a second look at the weight loss pill Qnexa
on Wednesday, after initially rejecting it because of concerns about heart
problems and possible birth defects.
